Literature DB >> 7786702

Hemodynamics of stenotic infrainguinal vein grafts: theoretic considerations.

G Papanicolaou1, K W Beach, R E Zierler, P R Detmer, D E Strandness.   

Abstract

We developed a theoretic model of arterial stenosis to study the relationship between perfusion pressure and regional hemodynamics in stenotic infrainguinal vein grafts in an attempt to identify grafts at high risk for failure. Our model was based on the concept of energy and mass conservation of the flowing blood. We used the modified Bernoulli equation (delta P = 4 delta V2) to calculate the maximum possible intrastenotic peak systolic velocity (PSV) from the systolic blood pressure. PSV was measured by means of duplex ultrasonography in infrainguinal bypasses up to the time of revision (nine grafts) or spontaneous thrombosis (two grafts). We related arm systolic blood pressure, intrastenotic PSV, and prestenotic PSV obtained from duplex examinations conducted prior to graft thrombosis or revision and applied our model to these stenotic vein grafts. Intrastenotic PSV was consistently lower than maximum PSV predicted from the Bernoulli equation. The highest measured intrastenotic PSV of 600 cm/sec would require a minimum perfusion pressure of 144 mm Hg. The lowest measured PSV (20 cm/sec) was considered the minimum "thrombotic threshold velocity." This model predicts that for parabolic profile flow in an 80% diameter-reducing axisymmetric stenosis (96% cross-sectional area reduction), a prestenotic PSV of 20 cm/sec would produce an intrastenotic PSV of 500 cm/sec requiring the equivalent potential energy of 100 mm Hg systolic blood pressure. Our theory implies that in patients with nocturnal hypotension thrombosis of stenotic vein grafts may occur.

Entities:  

Mesh:

Year:  1995        PMID: 7786702     DOI: 10.1007/BF02139659

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  4 in total

1.  Long-term patency and complications of ringed polytetrafluoroethylene grafts used for middle hepatic vein reconstruction in living-donor liver transplantation.

Authors:  I-Ji Jung; Shin Hwang; Tae-Yong Ha; Gi-Won Song; Dong-Hwan Jung; Chul-Soo Ahn; Deok-Bog Moon; Ki-Hun Kim; Gil-Chun Park; Young-In Yoon; Yo-Han Park; Hui-Dong Cho; Jae-Hyun Kwon; Yong-Kyu Chung; Sang-Hyun Kang; Sung-Gyu Lee
Journal:  Korean J Transplant       Date:  2020-03-31

2.  Usability of Cryopreserved Aortic Allografts for Middle Hepatic Vein Reconstruction During Living-Donor Liver Transplantation.

Authors:  Seok-Hwan Kim; Shin Hwang; Tae-Yong Ha; Gi-Won Song; Dong-Hwan Jung; Chul-Soo Ahn; Deok-Bog Moon; Ki-Hun Kim; Gil-Chun Park; Sung-Gyu Lee
Journal:  J Gastrointest Surg       Date:  2015-12-14       Impact factor: 3.452

3.  Patency of Hemashield grafts versus ringed Gore-Tex grafts in middle hepatic vein reconstruction for living donor liver transplantation.

Authors:  Sang Hoon Kim; Shin Hwang; Minjae Kim; Tae-Yong Ha; Gi-Won Song; Dong-Hwan Jung; Chul-Soo Ahn; Deok-Bog Moon; Ki-Hun Kim; Gil-Chun Park; Sung-Gyu Lee
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2021-02-28

4.  Hemashield Vascular Graft Is a Preferable Prosthetic Graft for Middle Hepatic Vein Reconstruction in Living Donor Liver Transplantation.

Authors:  Gil-Chun Park; Shin Hwang; Tae-Yong Ha; Gi-Won Song; Dong-Hwan Jung; Chul-Soo Ahn; Deok-Bog Moon; Ki-Hun Kim; Young-In Yoon; Hui-Dong Cho; Jae-Hyun Kwon; Yong-Kyu Chung; Sang-Hyun Kang; I-Ji Jung; Jin-Uk Choi; Sung-Gyu Lee
Journal:  Ann Transplant       Date:  2019-12-17       Impact factor: 1.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.